6533b85ffe1ef96bd12c27b0
RESEARCH PRODUCT
Influence of dibutyryl cyclic AMP on thymidine uptake by herpes simplex virus infected cells and the intracellular level of cyclic AMP.
Dietmar SchneiderDietrich FalkeK. Bittlingmaiersubject
DNA ReplicationUltraviolet RaysDeoxyribonucleosidesBiologyCycloheximidemedicine.disease_causeVirus ReplicationBiochemistry Genetics and Molecular Biology (miscellaneous)Thymidine KinaseVirusCell Linechemistry.chemical_compoundSpecies SpecificitymedicineCyclic AMPSimplexvirusThymine NucleotidesCycloheximideDadoBiological TransportDibutyryl Cyclic AMPMolecular biologyKineticsHerpes simplex viruschemistryBromodeoxyuridineBucladesineThymidine kinaseDNA ViralDactinomycinThymidineIntracellularThymidinedescription
Abstract Dibutyryl cyclic AMP inhibits the increase of dThd and BrdUrd transport normally observed after infection with Herpesvirus hominis, type I and II. Incorporation is also reduced. Inhibition of uptake is non-competitive as analysed by the Lineweaver-Burk plot. Addition of this drug to infected cells also reduces the activity of the thymidine kinase (EC 2.7.1.75). Transport of dUrd, dCyd and dAdo is not reduced. 4–8 h after infection with thymidine kinase (+) herpes strains the level of cAMP increases. On infection with a thymidine kinase (−) virus, only a small elevation of cAMP can be shown. It was also found that early addition of actinomycin D or of cycloheximide prevents the increase of the cAMP level. This increase seems to depend on the activity of the herpes genome, because ultraviolet irradiation of infective particles destroys this ability.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 1977-08-02 | Biochimica et biophysica acta |